Loading…

MOTS-c — mitochondrial open reading frame of the twelve S rRNA type-c — is a 16-residue peptide encoded within mitochondrial DNA rather than the nuclear genome. It was identified in 2015 and belongs to a small class of research peptides derived from the mitochondrial genome, a group that has reshaped how researchers think about mitochondria: not only as organelles receiving instructions from the nucleus, but as sources of signals in their own right.

What is MOTS-c?

Nearly every protein inside a mitochondrion is encoded in nuclear DNA, translated in the cytosol and imported into the organelle. Mitochondria retain only a small genome of their own, long assumed to encode a handful of respiratory-chain subunits and the RNA machinery needed to make them. MOTS-c is interesting because it does not fit that picture.

It is encoded in a short open reading frame inside the MT-RNR1 gene — the region of mitochondrial DNA that produces the 12S ribosomal RNA. That region was not thought to code for a peptide at all. The name is a direct description of where it was found rather than of anything it does.

MOTS-c was identified in 2015 by a team led by Changhan Lee at the USC Davis School of Gerontology, in work that followed an earlier mitochondrial-derived peptide called humanin. The discovery established mitochondrial-derived peptides as a category rather than a curiosity, and the field has since expanded to include several further members.

The conceptual shift matters more than the molecule itself. Communication from nucleus to mitochondrion is called anterograde signalling and has been understood for decades. Signals travelling the other way — retrograde signalling, from mitochondrion to nucleus — were known to exist but were poorly characterised. A peptide encoded in mitochondrial DNA that can act outside the organelle gave that pathway a concrete molecular candidate.

Mitochondrial-derived peptides as a class

To place MOTS-c correctly you need the category it belongs to. Mitochondrial-derived peptides are short peptides encoded within the mitochondrial genome, in reading frames that overlap regions previously annotated only as ribosomal RNA genes. Humanin, identified first, came from the 16S rRNA region. MOTS-c came from the 12S. Several further peptides, generally referred to as SHLPs, were subsequently described.

Two features make the class distinctive in research terms. First, because they are encoded in mitochondrial DNA, they are maternally inherited and subject to the particular mutation dynamics of the mitochondrial genome, which accumulates variation faster than nuclear DNA. Second, they appear to act outside the mitochondrion — in the cytosol, in the nucleus, and detectable in circulation — which is unusual for anything encoded inside the organelle.

That combination is why mitochondrial-derived peptides attract attention in ageing and metabolic research specifically. A signal whose source is the organelle most associated with age-related functional decline, and whose coding sequence varies between mitochondrial lineages, is an obvious candidate for explaining variation that nuclear genetics does not account for.

Reported mechanisms

MOTS-c has been described as binding casein kinase 2 and as influencing glucose handling in skeletal muscle, and it is frequently characterised in the literature as an exercise mimetic — meaning it produces, in model systems, changes overlapping those produced by physical exercise.

The original characterisation described an indirect route of action rather than a classical receptor interaction: effects on the folate–methionine one-carbon cycle leading to accumulation of an intermediate that in turn activates AMP-activated protein kinase, AMPK. AMPK is the cell's principal energy-status sensor, activated when the ratio of AMP to ATP rises, and it shifts metabolism away from storage and toward energy production. Reaching AMPK by altering the supply of an upstream metabolite, rather than by binding the kinase directly, is an unusual mechanism and a large part of why the peptide drew attention.

MOTS-c has also been reported to move into the nucleus under metabolic stress and to associate with regulatory elements governing stress-response gene expression. If that holds, it describes a peptide encoded in one genome that goes on to influence transcription from another — the clearest possible illustration of retrograde signalling.

Research contexts

Published work involving MOTS-c clusters in a few areas. Metabolic research is the largest, covering glucose handling, insulin sensitivity and skeletal-muscle energy metabolism in cell and animal models. Exercise physiology follows from the exercise-mimetic framing, with studies examining whether the peptide's levels change with physical activity and whether it mediates any of exercise's downstream effects.

Ageing and geroscience research forms a third cluster, consistent with the peptide's origins in a gerontology laboratory and with the broader interest in mitochondrial contributions to age-related decline. Population-genetics work has also examined whether variation in the MOTS-c coding region correlates with longevity or physical performance in particular cohorts, though findings in that area should be read with the usual caution that applies to candidate-gene association studies.

In our catalogue MOTS-c sits under metabolic research, though the mitochondrial angle overlaps heavily with the cellular research compounds, and researchers often draw from both.

Alongside this, MOTS-c is used straightforwardly as a reference peptide in assay development — a defined 16-residue sequence with a known mass, useful for validating detection methods for mitochondrial-derived peptides generally.

Regulatory and prohibited-substance status

MOTS-c is not approved by Health Canada, the FDA or any comparable authority for any use. It is not a drug, not a supplement and not a treatment for any condition.

Handling and storage in the laboratory

As a lyophilised peptide, MOTS-c is comparatively stable as a dry powder under cold storage and less so once reconstituted. Standard practice is to keep sealed vials frozen, protected from light and moisture, and to let a vial reach room temperature before opening so that atmospheric moisture does not condense inside it.

Two sequence-specific points are worth noting. MOTS-c contains two methionine residues, including one at the N-terminus, and methionine is among the residues most susceptible to oxidation; minimising air exposure during handling is therefore more than generic advice for this sequence. It also contains tryptophan, which is photosensitive, so light protection matters more here than for peptides lacking aromatic residues of that kind.

Reconstitution solvent, working concentration and aliquoting strategy depend on the assay and should follow the protocol of the study in question. The one point that generalises is to avoid repeated freeze-thaw cycling, which is the most common avoidable source of run-to-run variability, and to log lot numbers against experimental runs so that a batch change midway through a series does not become an undiagnosable confound later.

Verification and certificates of analysis

Purity claims mean little without the document behind them. Every MOTS-c lot NexPept lists is tested by an independent third-party laboratory using high-performance liquid chromatography and mass spectrometry, and the report is published openly rather than offered on request after purchase.

Certificates for the lots we have shipped are available in the NexPept Certificate of Analysis library, with the batch number on each vial matching a published report. From late September 2026 onward we have also been adding heavy-metal and endotoxin testing to those reports.

When reading any certificate, check that the batch number matches the vial you received, that both an identity method and a purity method are reported rather than purity alone, that the test date is recent, and that the issuing laboratory is named. Our quality standards page covers how our batches are tested and documented, and what research peptides are explains how research-grade material differs from a drug or a supplement. For the wider picture, our guide to research peptides in Canada covers sourcing and regulation, and buying peptides in Canada walks through what to check before you order.

Related research compounds

Researchers working on mitochondrial and metabolic questions frequently hold these alongside MOTS-c — SS-31 for the inner-membrane and cardiolipin side of mitochondrial function, NAD+ for the redox chemistry feeding the electron transport chain, and the cellular-maintenance peptides for adjacent structural questions:

Frequently asked questions

More from NexPept: browse the full research catalogue, read our other research articles, or check the frequently asked questions for ordering and documentation details.